Liposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD( Breakthrough Invasive Fungal Disease) in Patients With Malignant Hematological Diseases
N/A
This is a prospective, open label, controlled, single center real-world obs...
Status
Recruiting
Location
National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital
Start Date
2025-05-19
Trial ID
NCT07135778
Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia
PHASE2
The purpose of this study is to compare the efficacy and safety of venetocl...
Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole
PHASE2
SIR-POSA is a phase II trial of peripheral blood stem cell (PBSC) transplan...
Pharmacokinetics Variability of Posaconazole (PCZ) and Its Glucuronide Metabolite During Induction and Consolidation Treatments in Patients With Acute Myeloid Leukemia (AML): a Covariate Analysis With the Tablets Formulation and Evaluation of the Potential Risk of Hepatotoxicity
NA
Among its authorized indications, posaconazole (PCZ) is prescribed for prop...
Status
Unknown
Location
Centre Hospitalier Lyon Sud, Hematology department
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
PHASE3
The purpose of this pivotal study is to determine if intravenous Rezafungin...